GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Selling, General, & Admin. Expense

Implantica AG (OSTO:IMP A SDB) Selling, General, & Admin. Expense : kr Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Implantica AG's selling, general, & admin. expense for the six months ended in . 20 was kr0.00 Mil. Implantica AG does not have enough years/quarters to calculate its selling, general, & admin. expense for the trailing twelve months (TTM) ended in . 20.


Implantica AG Selling, General, & Admin. Expense Historical Data

The historical data trend for Implantica AG's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Selling, General, & Admin. Expense Chart

Implantica AG Annual Data
Trend
Selling, General, & Admin. Expense

Implantica AG Semi-Annual Data
Selling, General, & Admin. Expense

Competitive Comparison of Implantica AG's Selling, General, & Admin. Expense

For the Medical Devices subindustry, Implantica AG's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's Selling, General, & Admin. Expense Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Implantica AG's Selling, General, & Admin. Expense falls into.


;
;

Implantica AG Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.


Implantica AG  (OSTO:IMP A SDB) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Implantica AG Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Implantica AG's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines